Diskussionsleiter: E. Chavakis (Frankfurt am Main)
| (BS29) | The NADPH oxidase Nox4 promotes endothelial differentiation | |
| F. Hahner, F. Moll, O. Löwe, R. P. Brandes, K. Schröder, für die Studiengruppe: DZHK (Frankfurt am Main) | ||
| (BS30) | The NADPH organizers NoxO1 and p47phox are both mediators of diabetes-induced vascular dysfunction in mice | |
| F. Rezende, F. Moll, M. Walter, V. Helfinger, F. Hahner, P. Janetzko, C. Ringel, A. Weigert, I. Fleming, N. Weissmann, C. Kuenne, M. Looso, M. Rieger, R. P. Brandes, K. Schröder (Frankfurt am Main, Gießen, Bad Nauheim) | ||
| (BS31) | Characterization of the functional role of the proprotein convertase PCSK9 in vascular smooth muscle cells | |
| J. Winter, P.-C. Shukla, K. Kuschnerus, U. Landmesser (Berlin) | ||
| (BS32) | A functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis | |
| R. J. Sauter, M. Sauter, E. S. Reis, S. Ebenhöch, F. N. Emschermann, P. Kraft, P. Münzer, M. Mauler, J. Rheinländer, F. Edlich, T. E. Schäffer, D. Dürschmied, T. Geisler, O. Borst, M. Gawaz, C. Kleinschnitz, J. D. Lambris, H. Langer (Tübingen, Würzburg, Freiburg im Breisgau, Essen; Philadelphia, US) | ||
| (BS33) | Adventitial fibroblasts are key regulators of neointima formation | |
| J. Dutzmann, J. M. Daniel, L. Korte, F. Kloss, K. J. Croce, S. Offermanns, J. Bauersachs, D. G. Sedding (Hannover, Bad Nauheim; Boston, MA, US) | ||
| (BS34) | GPR55 deficiency promotes atherosclerosis development in mice. | |
| D. Hering, R. Guillamat-Prats, M. Rami, S. Steffens (München) |